查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594545

核苷酸市場：按產品類型、應用分類 - 2025-2030 年全球預測

Nucleotides Market by Product Type (Food Grade, Lab Grade), Application (Drug Discovery, Food & Animal Feed Additives, Pharmaceutical) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年核苷酸市值為6.0484億美元，預計2024年將達到6.523億美元，複合年成長率為8.33%，預計到2030年將達到10.5919億美元。

核苷酸是有機分子，是 DNA 和 RNA 等核酸的組成部分，在細胞過程中發揮重要作用。他們的需求範圍從遺傳訊息的儲存和傳遞到能量代謝的重要前體。核苷酸的應用多種多樣，包括用於抗病毒治療的藥物、牲畜和人類的營養食品以及用於研究和診斷的分子生物學工具。市場最終用途包括醫療和製藥、農業和生物技術領域。核苷酸市場受到蓬勃發展的生物技術產業以及對旨在增強腸道健康和免疫功能的動物強化產品不斷成長的需求的顯著影響。此外，對個人化醫療的日益關注和基因研究的進步正在進一步推動市場擴張。然而，該市場面臨的主要挑戰之一是核苷酸合成的高成本和治療應用中潛在的監管障礙。

主要市場統計
基準年[2023] 60484萬美元
預測年份 [2024] 6.523 億美元
預測年份 [2030] 1,059,190,000 美元
複合年成長率（%） 8.33%

新的商機在於開發用於治療用途的新型核苷酸類似物，特別是用於標靶癌症治療和病毒感染控制。此外，透過富含核苷酸的動物飼料擴大在水產養殖中的應用並提高農業產量也提供了有希望的成長途徑。為了利用這些機會，公司應該投資於降低成本和提高純度的創新生產技術，並與研究機構建立策略夥伴關係關係以推動產品開發。然而，市場成長受到合成核苷酸成本效益生產和大規模保持品質一致性方面的技術挑戰的限制。此外，不斷變化的監管和智慧財產權問題可能會進一步影響市場動態。最佳創新領域包括開發永續生產方法、提高核苷酸穩定性以延長保存期限以及探索多功能核苷酸產品。該市場的特點是技術快速進步和競爭格局激烈，協作和持續創新是保持市場主導地位的關鍵。

市場動態：揭示快速發展的核苷酸市場的關鍵市場洞察

供需的動態相互作用正在改變核苷酸市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 對核苷酸補充品的需求不斷成長
    • 增加核苷酸在診斷研究中的使用
    • 動物飼料中的使用量迅速增加
  • 市場限制因素
    • 核苷酸產品高成本
  • 市場機會
    • 提高核苷酸產量
    • 市場參與企業之間的合併活動增加，以實現更好的商業化
  • 市場問題
    • 關於核苷酸的嚴格規則

波特五力：駕馭核苷酸市場的策略工具

波特的五力框架是了解核苷酸市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解核苷酸市場的外部影響

外部宏觀環境因素在塑造核苷酸市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解核苷酸市場的競爭格局

核苷酸市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣：核苷酸市場供應商績效評估

FPNV定位矩陣是評估核苷酸市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製核苷酸市場的成功之路

核苷酸市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對核苷酸補充品的需求增加
      • 診斷研究中核苷酸的使用增加
      • 在動物飼料中的指數級使用
    • 抑制因素
      • 核苷酸產品高成本
    • 機會
      • 提高核苷酸產量
      • 市場相關人員之間的合併活動增加，以實現更好的商業化
    • 任務
      • 關於核苷酸的嚴格規則
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章 核苷酸市場：依產品類型

  • 介紹
  • 食品級
  • 實驗室級

第7章 核苷酸市場：依應用分類

  • 介紹
  • 藥物發現
  • 食品和動物飼料添加劑
  • 製藥

第8章美洲核苷酸市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太核苷酸市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲的核苷酸市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • Biosynth Ltd.
  • Bosche Scientific LLC
  • CJ CheilJedang Corp.
  • Daesang Corporation
  • Ebrator Biochemicals
  • Glentham Life Sciences Ltd.
  • Jena Bioscience GmbH
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • New England Biolabs Inc.
  • Otto Chemie Pvt. Ltd.
  • Promega Corporation
  • Prosol SpA
  • Thermo Fisher Scientific Inc.
Product Code: MRR-957C47F9323F

The Nucleotides Market was valued at USD 604.84 million in 2023, expected to reach USD 652.30 million in 2024, and is projected to grow at a CAGR of 8.33%, to USD 1,059.19 million by 2030.

Nucleotides are organic molecules that serve as the building blocks of nucleic acids like DNA and RNA, playing critical roles in cellular processes. Their necessity spans from genetic information storage and transfer to being essential precursors in energy metabolism. The application of nucleotides is diverse, encompassing pharmaceuticals for antiviral therapies, dietary supplements for livestock and humans, and molecular biology tools for research and diagnostics. The market's end-use scope includes healthcare and pharmaceuticals, agriculture, and biotechnology sectors. The nucleotide market is significantly influenced by the burgeoning biotechnology industry and the increasing demand for fortified animal nutrition products, which aim to enhance gut health and immune function. Additionally, the rising focus on personalized medicine and advancements in genetic research further fuel market expansion. However, one of the primary challenges faced by this market is the high cost of nucleotide synthesis and potential regulatory hurdles in therapeutic applications.

KEY MARKET STATISTICS
Base Year [2023] USD 604.84 million
Estimated Year [2024] USD 652.30 million
Forecast Year [2030] USD 1,059.19 million
CAGR (%) 8.33%

Emerging opportunities lie in the development of novel nucleotide analogs for therapeutic use, particularly in targeted cancer treatments and viral infection management. Additionally, expanding applications in aquaculture and improved agricultural yields through nucleotide-enhanced animal feed represent prospective growth avenues. To capitalize on these opportunities, companies should invest in innovative production technologies that reduce costs and improve purity, as well as form strategic partnerships with research institutions to drive product development. Yet, market growth is constrained by technological challenges in the cost-efficient production of synthetic nucleotides and maintaining quality consistency at scale. Moreover, evolving regulations and intellectual property rights issues could further impact market dynamics. The best areas of innovation include developing sustainable production methods, enhancing nucleotide stability for extended shelf life, and exploring multi-functional nucleotide products. The market is characterized by rapid technological advancements and a competitive landscape, with collaboration and continual innovation being key to maintaining an edge in the market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Nucleotides Market

The Nucleotides Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand of nucleotide supplements
    • Increase use of nucleotide in diagnostic research
    • Exponential use in animal feed
  • Market Restraints
    • High cost of nucleotide based products
  • Market Opportunities
    • Improvements in nucleotide manufacturing
    • Increasing amalgamation activities between market players for better commercialization
  • Market Challenges
    • Stringent rules regarding nucleotides

Porter's Five Forces: A Strategic Tool for Navigating the Nucleotides Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Nucleotides Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Nucleotides Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Nucleotides Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Nucleotides Market

A detailed market share analysis in the Nucleotides Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Nucleotides Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Nucleotides Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Nucleotides Market

A strategic analysis of the Nucleotides Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nucleotides Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Biosynth Ltd., Bosche Scientific LLC, CJ CheilJedang Corp., Daesang Corporation, Ebrator Biochemicals, Glentham Life Sciences Ltd., Jena Bioscience GmbH, Merck KGaA, Meridian Bioscience, Inc., New England Biolabs Inc., Otto Chemie Pvt. Ltd., Promega Corporation, Prosol S.p.A., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Nucleotides Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Food Grade and Lab Grade.
  • Based on Application, market is studied across Drug Discovery, Food & Animal Feed Additives, and Pharmaceutical.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand of nucleotide supplements
      • 5.1.1.2. Increase use of nucleotide in diagnostic research
      • 5.1.1.3. Exponential use in animal feed
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of nucleotide based products
    • 5.1.3. Opportunities
      • 5.1.3.1. Improvements in nucleotide manufacturing
      • 5.1.3.2. Increasing amalgamation activities between market players for better commercialization
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent rules regarding nucleotides
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Nucleotides Market, by Product Type

  • 6.1. Introduction
  • 6.2. Food Grade
  • 6.3. Lab Grade

7. Nucleotides Market, by Application

  • 7.1. Introduction
  • 7.2. Drug Discovery
  • 7.3. Food & Animal Feed Additives
  • 7.4. Pharmaceutical

8. Americas Nucleotides Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Nucleotides Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Nucleotides Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Biosynth Ltd.
  • 3. Bosche Scientific LLC
  • 4. CJ CheilJedang Corp.
  • 5. Daesang Corporation
  • 6. Ebrator Biochemicals
  • 7. Glentham Life Sciences Ltd.
  • 8. Jena Bioscience GmbH
  • 9. Merck KGaA
  • 10. Meridian Bioscience, Inc.
  • 11. New England Biolabs Inc.
  • 12. Otto Chemie Pvt. Ltd.
  • 13. Promega Corporation
  • 14. Prosol S.p.A.
  • 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. NUCLEOTIDES MARKET RESEARCH PROCESS
  • FIGURE 2. NUCLEOTIDES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NUCLEOTIDES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NUCLEOTIDES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES NUCLEOTIDES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES NUCLEOTIDES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. NUCLEOTIDES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. NUCLEOTIDES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NUCLEOTIDES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NUCLEOTIDES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NUCLEOTIDES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NUCLEOTIDES MARKET DYNAMICS
  • TABLE 7. GLOBAL NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NUCLEOTIDES MARKET SIZE, BY FOOD GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NUCLEOTIDES MARKET SIZE, BY LAB GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NUCLEOTIDES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NUCLEOTIDES MARKET SIZE, BY FOOD & ANIMAL FEED ADDITIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES NUCLEOTIDES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. NUCLEOTIDES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. NUCLEOTIDES MARKET, FPNV POSITIONING MATRIX, 2023